Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-05 08:03 am Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 14,766,892 8.1% | 1,700,689 (+13.02%) | View |
2021-01-07 09:56 am Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 18,147,961 9.997% | -38,750 (-0.21%) | View |
2020-09-10 12:00 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 18,186,711 10.03% | 1,857,391 (+11.37%) | View |
2020-02-14 12:03 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 22,004,065 12.2% | 3,699,902 (+20.21%) | View |
2020-02-12 2:40 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO | 16,329,320 9.09% | 2,129,047 (+14.99%) | View |
2020-02-12 08:02 am Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 16,536,780 9.2% | 994,876 (+6.40%) | View |
2020-02-10 07:32 am Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 13,066,203 7.3% | -521,984 (-3.84%) | View |
2020-02-06 1:42 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRUDENTIAL FINANCIAL INC PRU | 7,325,667 4.1% | -4,386,453 (-37.45%) | View |
2020-02-04 2:12 pm Sale | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | JENNISON ASSOCIATES LLC | 7,100,173 4% | -4,500,287 (-38.79%) | View |